Kyle Bass’s New Tack: Dispute the Patent, Short the Stock

Hedge-fund manager Kyle Bass’s patent challenge against Jazz Pharmaceuticals illustrates a new strategy of challenging U.S. drug patents while shorting shares of the holder and wagering on potential winners.

Speak Your Mind

Subscribe to get this amazing EBOOK FREE

Real Estate 101 - Buying Your First Home!

By subscribing to this newsletter you agree to our Privacy Policy